LTC unions urge CDC to revise masking guidance for vaccinated individuals to protect workers
By
Kathleen Steele Gaivin
May 21, 2021
Unions representing registered nurses and others who work in long-term care are urging the Centers for Disease Control and Prevention to reconsider its May 13 guidance on mask-wearing and social distancing...
What practical options are available to enhance the flexibility of my service offering?
By
Jim Moore
Aug 01, 2017
You’ve got questions? We’ve got answers.
Yoga proves to be effective treatment for chronic lower back pain
By
Alyssa Salela
Jul 07, 2017
Yoga classes designed to address lower back pain produced results similar to physical therapy for people with chronic lower back pain, a Boston Medical Center study has found.
What unique challenges do operators face this year?
By
Jim Moore
Apr 02, 2018
You’ve got questions. We’ve got answers. There are three big challenges.
Biden’s day 1 pandemic plan promising for HCBS, home care leader says
By
Joe Jancsurak
Jan 25, 2021
Home care providers were pleased to learn that the new administration’s pandemic preparedness plan offers a nod to home care for older adults.
Mediterranean diet tied to frailty prevention
Jul 12, 2022
Higher total carotenoid intake also was associated with frailty prevention.
Retinal layer thickness linked to cognitive decline in older adults
May 27, 2022
Thinner baseline total macular retinal nerve fiber layer thickness was associated with a larger decline in cognitive function test scores during follow-up.
Periodontitis may raise risk for new cardiovascular events
Sep 01, 2021
The presence of a severe gum infection at baseline was linked to increased odds for new cardiovascular events.
Racial, ethnic disparities explored in subjective cognitive decline
Jul 08, 2021
More Black and Hispanic adults than white adults report subjective cognitive decline at age 45 to 54 years.
AAN issues review of evidence for aducanumab in Alzheimer’s disease
Mar 03, 2022
A class I study shows that single doses of aducanumab are safe and well-tolerated; class II studies show reduced amyloid deposition on brain PET at one year.